Invention Grant
- Patent Title: HLA-A24-restricted cancer antigen peptides
- Patent Title (中): HLA-A24限制性癌抗原肽
-
Application No.: US12142372Application Date: 2008-06-19
-
Publication No.: US07666985B2Publication Date: 2010-02-23
- Inventor: Haruo Sugiyama , Masashi Gotoh , Hideo Takasu
- Applicant: Haruo Sugiyama , Masashi Gotoh , Hideo Takasu
- Applicant Address: JP Suita-shi JP Tokyo-to JP Osaka-shi
- Assignee: International Institute of Cancer Immunology, Inc.,Chugai Seiyaku Kabushiki Kaisha,Dainippon Sumitomo Pharma Co., Ltd.
- Current Assignee: International Institute of Cancer Immunology, Inc.,Chugai Seiyaku Kabushiki Kaisha,Dainippon Sumitomo Pharma Co., Ltd.
- Current Assignee Address: JP Suita-shi JP Tokyo-to JP Osaka-shi
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2002-171518 20020612; JP2002-275572 20020920
- Main IPC: C08G69/10
- IPC: C08G69/10 ; A61K38/00 ; A61K51/00
Abstract:
HLA-A24-restricted peptides derived from WT1 which have an activity to induce CTLs in vivo, polynucleotides encoding said peptides, cancer vaccines using those peptides or polynucleotides in vivo or in vitro, or the like are provided. The cancer vaccines of the present invention may be used to treat many cancer patients.
Public/Granted literature
- US20090099090A1 HLA-A24-RESTRICTED CANCER ANTIGEN PEPTIDES Public/Granted day:2009-04-16
Information query
